Search

Your search keyword '"fragment molecular orbital"' showing total 1,097 results

Search Constraints

Start Over You searched for: Descriptor "fragment molecular orbital" Remove constraint Descriptor: "fragment molecular orbital"
1,097 results on '"fragment molecular orbital"'

Search Results

1. Size‐consistency and orbital‐invariance issues revealed by VQE‐UCCSD calculations with the FMO scheme.

2. Automatic molecular fragmentation by evolutionary optimisation

3. Automatic molecular fragmentation by evolutionary optimisation.

4. The Pivotal Distinction between Antagonists' and Agonists' Binding into Dopamine D4 Receptor—MD and FMO/PIEDA Studies.

5. In Silico Design of Natural Inhibitors of ApoE4 from the Plant Moringa oleifera : Molecular Docking and Ab Initio Fragment Molecular Orbital Calculations.

6. The Pivotal Distinction between Antagonists’ and Agonists’ Binding into Dopamine D4 Receptor—MD and FMO/PIEDA Studies

7. In Silico Design of Natural Inhibitors of ApoE4 from the Plant Moringa oleifera: Molecular Docking and Ab Initio Fragment Molecular Orbital Calculations

8. The Importance of Charge Transfer and Solvent Screening in the Interactions of Backbones and Functional Groups in Amino Acid Residues and Nucleotides.

9. Modification of MM force fields around heme-Fe in the CYP–ligand complex and ab initio FMO calculations for the complex.

10. Identification of Novel Natural Product Inhibitors against Matrix Metalloproteinase 9 Using Quantum Mechanical Fragment Molecular Orbital-Based Virtual Screening Methods.

11. A Study on the Effect of the Substituent against PAK4 Inhibition Using In Silico Methods.

12. Specific interactions between the alkaline protease of P. aeruginosa and its natural peptide inhibitor: ab initio molecular simulations.

13. Identification of key stabilizing interactions of amyloid‐β oligomers based on fragment molecular orbital calculations on macrocyclic β‐hairpin peptides.

14. Structural change of retinoic-acid receptor-related orphan receptor induced by binding of inverse-agonist: Molecular dynamics and ab initio molecular orbital simulations

15. Ligand binding: evaluating the contribution of the water molecules network using the Fragment Molecular Orbital method.

16. The Importance of Charge Transfer and Solvent Screening in the Interactions of Backbones and Functional Groups in Amino Acid Residues and Nucleotides

18. Identification of Novel Natural Product Inhibitors against Matrix Metalloproteinase 9 Using Quantum Mechanical Fragment Molecular Orbital-Based Virtual Screening Methods

19. A Study on the Effect of the Substituent against PAK4 Inhibition Using In Silico Methods

20. Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice.

21. Multiple Virtual Screening Strategies for the Discovery of Novel Compounds Active Against Dengue Virus: A Hit Identification Study.

23. Elucidating specific interactions for designing novel pyrrolamide derivatives as potential GyrB inhibitors based on ab initio fragment molecular orbital calculations.

24. Effect of Zn ion on the structure and electronic states of Aβ nonamer: molecular dynamics and ab initio molecular orbital calculations.

25. Specific interactions between 2-trans enoyl-acyl carrier protein reductase and its ligand: Protein-ligand docking and ab initio fragment molecular orbital calculations.

26. Ligand chirality can affect histidine protonation of vitamin-D receptor: ab initio molecular orbital calculations in water.

27. An insight of early PrP‐E200K aggregation by combined molecular dynamics/fragment molecular orbital approaches.

28. Proposal of Potent Inhibitors for a Bacterial Cell Division Protein FtsZ: Molecular Simulations Based on Molecular Docking and ab Initio Molecular Orbital Calculations

31. Interaction Analysis on the SARS-CoV-2 Spike Protein Receptor Binding Domain Using Visualization of the Interfacial Electrostatic Complementarity

33. Analytic second derivatives for the efficient electrostatic embedding in the fragment molecular orbital method.

34. ONIOM and FMO‐EDA study of metabotropic glutamate receptor 1: Quantum insights into the allosteric binding site.

35. Proposal of potent inhibitors for vitamin-D receptor based on ab initio fragment molecular orbital calculations.

36. Fluorescent pseudorotaxanes of a quinodicarbocyanine dye with gamma cyclodextrin.

37. Specific interactions between mycobacterial FtsZ protein and curcumin derivatives: Molecular docking and ab initio molecular simulations.

38. Quantum Mechanics Helps Uncover Atypical Recognition Features in the Flavin Mononucleotide Riboswitch

39. Partitioning of the Vibrational Free Energy

40. Intermolecular Interaction Analyses on SARS-CoV-2 Spike Protein Receptor Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor-Blocking Antibody/Peptide Using Fragment Molecular Orbital Calculation

42. FMODB: The World’s First Database of Quantum Mechanical Calculations for Biomacromolecules Based on the Fragment Molecular Orbital Method

43. Acceleration of Environmental Electrostatic Potential Using Cholesky Decomposition with Adaptive Metric (CDAM) for Fragment Molecular Orbital (FMO) Method

44. Proposal for novel curcumin derivatives as potent inhibitors against Alzheimer’s disease: Ab initio molecular simulations on the specific interactions between amyloid-beta peptide and curcumin.

45. Specific interactions between zinc metalloproteinase and its inhibitors: Ab initio fragment molecular orbital calculations.

46. Specific interactions between androgen receptor and its ligand: ab initio molecular orbital calculations in water.

47. Specific interactions between vitamin-D receptor and its ligands: Ab initio molecular orbital calculations in water.

48. Specific interactions between amyloid-β peptides in an amyloid-β hexamer with three-fold symmetry: Ab initio fragment molecular orbital calculations in water.

49. Fragment molecular orbital (FMO) calculations on DNA by a scaled third-order Møller-Plesset perturbation (MP2.5) scheme.

50. Proposal of novel ApoE4 inhibitors from the natural spice Cinnamon for the treatment of Alzheimer's disease: Ab initio molecular simulations.

Catalog

Books, media, physical & digital resources